Interventions that reduce perceived pill burden such as fixed-dose combinations, pillbox aids, and side-effect counselling may be a more targeted lever for improving adherence in this setting than broad socio-demographic targeting.
Abstract
Tuberculosis (TB) remains a major public health challenge in Uganda despite the availability of effective treatment. Non-adherence to anti-TB medication continues to undermine national TB control efforts, contributing to treatment failure, drug resistance, prolonged infectiousness, and increased morbidity and mortality. Most Ugandan evidence on treatment adherence comes from national referral or urban public facilities, leaving adherence patterns at smaller, private not-for-profit facilities comparatively unexamined.
This study assessed the prevalence of non-adherence and its associated patient-related, therapy-related, and health-system factors among tuberculosis patients attending Ishaka Adventist Hospital in Bushenyi District, Uganda.
An analytical cross-sectional study was conducted among 152 adult TB patients who had been on treatment for at least three months, recruited consecutively from the TB clinic during the study period, August 2025 to December 2025. Data were collected using structured interviewer-administered questionnaires and TB treatment registers. For this analysis, non-adherence was defined as taking less than 80% of prescribed doses in the previous month. Bivariate screening (χ2/Fisher’s exact,
p
< 0.20) was followed by multivariable logistic regression to identify factors associated with non-adherence. Analyses were performed in IBM SPSS version 27.
Of 152 enrolled patients, adherence could be determined for 151; the prevalence of non-adherence was 27.2% (41/151). Among the 81 patients who reported missing at least one dose, the most frequently cited reasons were forgetfulness (93.8%), being busy (39.5%), and side effects (39.5%). HIV was prevalent (53.9%, 82/152) but was not associated with non-adherence (χ²
p
= 0.580; mean adherence 87.2% in HIV-positive vs. 89.6% in HIV-negative participants, Mann-Whitney
p
= 0.384). No socio-demographic factor was significantly associated with non-adherence in the adjusted model. Pill burden was independently associated with non-adherence after adjustment for age (adjusted OR 2.35, 95% CI 1.04–5.32,
p
= 0.040).
Around one in four TB patients at this facility were non-adherent, and pill burden was the only factor independently associated with non-adherence after adjustment. Interventions that reduce perceived pill burden such as fixed-dose combinations, pillbox aids, and side-effect counselling may be a more targeted lever for improving adherence in this setting than broad socio-demographic targeting.
Background: Tuberculosis (TB) remains a critical global public health burden. Indonesia ranks second worldwide in TB incidence, and treatment success rates at primary care level remain below national targets. Medication non-adherence is a leading driver of therapy failure and drug resistance. Objective: This study aime...
Ahmad Suriyadi Muslim, Delia Putri Hedianti, Galih Kurniawan· Jurnal kesehatan dr. Soeband...· 0 citations
Abstract Background In 2024, tuberculosis (TB) caused the highest number of deaths from a single infection globally. Despite the decline in TB incidence rates over the past decade, treatment failure rates still remain substantial in Armenia. Studies exploring factors related to TB treatment failure are scarce. This stu...
A. Demirchyan, V. Petrosyan, L. Musheghyan· European Journal of Public H...· 0 citations
Background Timely treatment initiation is central to drug-resistant tuberculosis (DR-TB) control. Uganda's National TB and Leprosy Programme recommends DR-TB treatment initiation within seven (Okethwangu et al., 2019 (7)) days of rifampicin-resistant TB (RR-TB) diagnosis, but the extent of delay and its drivers are poo...
L. Nakiyingi, Herbert Kayonga, S. Zawedde-Muyanja et al.· Journal of Clinical Tubercul...· 0 citations
Background There is a significant intersection between Tuberculosis (TB) and HIV, which has contributed greatly to the disease burden, especially in Nigeria. Among approximately 1.9 million people living with HIV (PLHIV), an estimated 46,000 also had TB in 2019 alone. HIV-associated TB incidence has continuously increa...
A. Aigbokhaode, A. Jegede, N. Orhue et al.· Journal of the International...· 0 citations
Background: Tuberculosis (TB) is a communicable infectious disease caused by Mycobacterium tuberculosis and remains a major public health challenge. Successful TB treatment largely depends on patients’ adherence to antituberculosis drug (ATD) regimens, including the prescribed dosage, schedule, and duration. However, p...
Background: Tuberculosis (TB) remains a significant global health concern, with efforts aimed at ending the epidemic by 2035. Tuberculosis Preventive Therapy (TPT) is a key intervention to prevent progression from latent TB infection to active disease, especially in children under fifteen, who were at higher risk parti...
Jackson K. Limo, David Masinde, S. Korir· International journal of res...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.